Ginkgo biloba
( DrugBank: Ginkgo biloba / KEGG DRUG: Ginkgo )
3 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
13 | Multiple sclerosis | 2 |
18 | Spinocerebellar degeneration | 1 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
47 | Buerger disease | 1 |
13. Multiple sclerosis
Clinical trials : 3,685 / Drugs : 1,932 - (DrugBank : 355) / Drug target genes : 263 - Drug target pathways : 237
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
18. Spinocerebellar degeneration
Clinical trials : 83 / Drugs : 83 - (DrugBank : 31) / Drug target genes : 30 - Drug target pathways : 53
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
47. Buerger disease
Clinical trials : 14 / Drugs : 18 - (DrugBank : 13) / Drug target genes : 7 - Drug target pathways : 19
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|